Sequential Administration Of Nivolumab And Ipilimumab With A Planned Switch In Patients With Advanced Melanoma (CheckMate 064): An Open-label, Randomised, Phase 2 Trial
Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, Jeffrey A Sosman, Craig L Slingluff, Donald P Lawrence, Theodore F Logan, Lynn M Schuchter, Suresh Nair, Leslie Fecher, Elizabeth I Buchbinder, Elmer Berghorn, Mary Ruisi, George Kong, Joel Jiang, Christine Horak, F Stephen Hodi
Twitter
Facebook
LinkedIn
Email